Paige Cramer Lacatena

Paige Cramer Lacatena has extensive experience in the fields of neuroscience and business development, having held significant roles at Merck from September 2019 to August 2021, including Director of Business Development and Licensing for Neurology and Ophthalmology, as well as Global Senior Director of Scientific Affairs for Neuroscience, Anesthesia, and Perioperative Care. Prior to Merck, Paige co-founded ReXceptor Inc. in March 2012, focusing on the advancement of RXR agonist bexarotene into clinical trials. Academic qualifications include a Ph.D. in Neuroscience from Case Western Reserve University School of Medicine and a B.S. in Biology and Biomedical Engineering from Tufts University, with notable research experience in Alzheimer's disease at the Gary Landreth Alzheimer's Research laboratory during Ph.D. candidacy.